Ameritas Investment Partners, Inc. - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$111,990
+9.6%
9,580
+26.0%
0.00%0.0%
Q2 2023$102,184
-18.9%
7,6030.0%0.00%
-20.0%
Q1 2023$126,058
+12.3%
7,6030.0%0.01%
+25.0%
Q4 2022$112,220
+15.7%
7,6030.0%0.00%0.0%
Q3 2022$97,000
+83.0%
7,6030.0%0.00%
+100.0%
Q2 2022$53,000
-15.9%
7,6030.0%0.00%0.0%
Q1 2022$63,000
+23.5%
7,6030.0%0.00%0.0%
Q4 2021$51,000
+6.2%
7,603
-16.1%
0.00%0.0%
Q3 2021$48,000
-7.7%
9,0630.0%0.00%0.0%
Q2 2021$52,000
+23.8%
9,0630.0%0.00%0.0%
Q1 2021$42,000
+40.0%
9,0630.0%0.00%
+100.0%
Q4 2020$30,000
+11.1%
9,0630.0%0.00%0.0%
Q3 2020$27,000
-35.7%
9,0630.0%0.00%
-50.0%
Q2 2020$42,000
+20.0%
9,0630.0%0.00%0.0%
Q1 2020$35,000
+2.9%
9,0630.0%0.00%0.0%
Q4 2019$34,000
-29.2%
9,0630.0%0.00%0.0%
Q3 2019$48,000
+37.1%
9,0630.0%0.00%0.0%
Q2 2019$35,000
-23.9%
9,0630.0%0.00%0.0%
Q1 2019$46,000
+170.6%
9,0630.0%0.00%
+100.0%
Q4 2018$17,000
-50.0%
9,0630.0%0.00%
-50.0%
Q3 2018$34,000
+21.4%
9,0630.0%0.00%
+100.0%
Q2 2018$28,000
+86.7%
9,063
+44.3%
0.00%0.0%
Q1 2018$15,000
-40.0%
6,2800.0%0.00%0.0%
Q4 2017$25,000
+47.1%
6,2800.0%0.00%0.0%
Q3 2017$17,0000.0%6,2800.0%0.00%0.0%
Q2 2017$17,0006,2800.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders